PTK6 抗体
PTK6 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
PTK6 适用: 人, 小鼠, 大鼠 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
PTK6 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
PTK6 抗体 by 适用
Find PTK6 抗体 for a variety of species such as anti-Human PTK6, anti-Mouse PTK6, anti-Rat PTK6. The species listed below are among those available. Click on a link to go to the corresponding products.
PTK6 抗体 by 抗体来源
Find PTK6 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
PTK6 抗体 by 克隆形成能力
Find available monoclonal or polyclonal PTK6 抗体. Click on a link to go to the corresponding products.
PTK6 抗体 by 克隆
Find PTK6 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular PTK6 抗体
- (3)
- (3)
- (3)
- (3)
- (2)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
Latest Publications for our PTK6 抗体
: "Overexpression of PTK6 predicts poor prognosis in bladder cancer patients." in: Journal of Cancer, Vol. 8, Issue 17, pp. 3464-3473, (2018) (PubMed).: "The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling." in: Marine drugs, Vol. 12, Issue 4, pp. 2282-304, (2014) (PubMed).
: "Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors." in: European journal of medicinal chemistry, Vol. 73, pp. 310-24, (2014) (PubMed).
: "Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma." in: Medical oncology (Northwood, London, England), Vol. 31, Issue 12, pp. 317, (2014) (PubMed).
: "Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models." in: PLoS ONE, Vol. 9, Issue 5, pp. e97622, (2014) (PubMed).
: "Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling." in: Organic & biomolecular chemistry, Vol. 12, Issue 28, pp. 5295-303, (2014) (PubMed).
: "Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo." in: Molecular oncology, Vol. 9, Issue 1, pp. 282-94, (2014) (PubMed).
: "Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma." in: Journal of translational medicine, Vol. 11, pp. 59, (2013) (PubMed).
: "Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells." in: Oncogene, Vol. 22, Issue 27, pp. 4212-20, (2003) (PubMed).
: "Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK." in: Molecular and cellular biology, Vol. 23, Issue 1, pp. 92-103, (2002) (PubMed).
Aliases for PTK6 抗体
protein tyrosine kinase 6 (PTK6) 抗体PTK6 protein tyrosine kinase 6 (Ptk6) 抗体
protein tyrosine kinase 6 (Ptk6) 抗体
PTK6 protein tyrosine kinase 6b (ptk6b) 抗体
BRK 抗体
Sik 抗体
tks 抗体
Tksk 抗体
zgc:153964 抗体